Latest data from July 29, 2022
Number of Health Center respondents = 17 (71% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics | Value |
---|---|
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 2,240 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 74.03% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 378 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 81.68% |
Patients by Race and Ethnicity
Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
---|---|---|
White, Non-Hispanic/Latino Patients | 22.32% | 15.61% |
White, Hispanic/Latino Patients | 29.60% | 34.92% |
Black/African American, Non-Hispanic/Latino Patients | 17.68% | 12.70% |
Black/African American, Hispanic/Latino Patients | 1.56% | 1.32% |
Asian Patients3 | 1.21% | 1.32% |
American Indian/Alaska Native Patients3 | 2.95% | 2.12% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.76% | 0.79% |
Patients with More Than One Race3 | 7.32% | 13.23% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.54% | 3.17% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 9.64% | 10.05% |
Unreported/Refused to Report Race and Ethnicity | 4.42% | 4.76% |
Patients Vaccinated
Metrics | Value |
---|---|
COVID-19 Immunization Series Initiated | 380 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 86.27% |
COVID-19 Immunization Series Completed | 201 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 75.66% |
COVID-19 Immunization Series Additional | 774 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 78.19% |
Vaccinations by Race and Ethnicity
Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
---|---|---|---|
White, Non-Hispanic/Latino Patients | 12.89% | 22.89% | 20.28% |
White, Hispanic/Latino Patients | 41.58% | 35.82% | 33.72% |
Black/African American, Non-Hispanic/Latino Patients | 20.26% | 15.92% | 16.28% |
Black/African American, Hispanic/Latino Patients | 2.89% | 3.48% | 2.97% |
Asian Patients3 | 2.63% | 3.48% | 2.84% |
American Indian/Alaska Native Patients3 | 1.84% | 1.99% | 4.26% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.26% | 1.49% | 0.65% |
Patients with More Than One Race3 | 6.84% | 4.98% | 3.62% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.74% | 3.98% | 8.40% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.42% | 1.49% | 3.49% |
Unreported/Refused to Report Race and Ethnicity | 2.63% | 4.48% | 3.49% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics | Value |
---|---|
Less Than 1 Hour | 5.88% |
1 to 24 Hours | 29.41% |
More Than 24 Hours | 64.71% |
N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics | Value |
---|---|
Financial reimbursement for costs associated with vaccine administration | 11.76% |
Staffing to administer the vaccine | 29.41% |
Vaccine confidence | 52.94% |
Vaccine storage capacity | 0.00% |
Vaccine supply | 0.00% |
Other | 11.76% |
None | 17.65% |
Operations and Staff
Metrics | Value |
---|---|
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 17.65% |
Average Percent of Health Center Visits Conducted Virtually | 15.00% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics | Value |
---|---|
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 58.82% |
Number of Mobile Van Sites | 1 |
Number of Pop-up Clinics | 31 |
Number of School-Based Vaccination Sites | 13 |
Number of Family Vaccination Clinics | 8 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Direct provision of monoclonal antibody therapies | 5.88% |
Refer patients to another organization that provides monoclonal antibody therapies | 41.18% |
None | 52.94% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Access to therapeutics | 5.88% |
Patient awareness/education | 17.65% |
Staffing capacity | 17.65% |
Therapy administration/onsite logistics | 23.53% |
Other | 5.88% |
None | 47.06% |
Test Kit Distribution
Metrics | Value |
---|---|
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 11 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 1,725 |
Test Kit Distribution Methods4
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 63.64% |
Provided to General Public Who Came to the Health Center | 72.73% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 45.45% |
Provided at Other Community Events | 45.45% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 18.18% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 27.27% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 27.27% |
Provided to school-age children and/or their families directly or through partnerships with schools | 36.36% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 9.09% |
Other | 0.00% |
N95 Mask Distribution
Metrics | Value |
---|---|
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 7 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 1,426 |
N95 Mask Distribution Methods5
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 85.71% |
Provided to General Public Who Came to the Health Center | 71.43% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 42.86% |
Provided at Other Community Events | 71.43% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 14.29% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 14.29% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 14.29% |
Provided to school-age children and/or their families directly or through partnerships with schools | 28.57% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
Other | 0.00% |
Oral Antiviral Medication Distribution
Metrics | Value |
---|---|
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 2 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 69.57% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity | Value |
---|---|
White, Non-Hispanic/Latino Patients | 30.43% |
White, Hispanic/Latino Patients | 56.52% |
Black/African American, Non-Hispanic/Latino Patients | 0.00% |
Black/African American, Hispanic/Latino Patients | 0.00% |
Asian Patients3 | 4.35% |
American Indian/Alaska Native Patients3 | 0.00% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
Patients with More Than One Race3 | 0.00% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 8.70% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
Unreported/Refused to Report Race and Ethnicity | 0.00% |
Oral Antiviral Medication Distribution by Population Type
Metrics | Value |
---|---|
Migratory/Agricultural Workers | 4.35% |
Patients Experiencing Homelessness | 4.35% |
Patients Who Are Residents of Public Housing | 4.35% |
Patients with Limited English Proficiency | 56.52% |
Children Under 18 Years of Age | 0.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.